[Micra™ leadless pacemaker : Clinical experience and perspectives].
Authors of this article are:
Steinwender C, Blessberger H, Kiblböck D, Saleh K, Kammler J.
A summary of the article is shown below:
Leadless pacemakers have the potential to fundamentally change the field of device therapy. As leads and generator pockets are no longer needed with this technology, many potentially dangerous complications of conventional pacemaker systems like lead fractures, lead endocarditis or pocket infections can be effectively avoided. At present, Micra™ (Medtronic Inc., Minneapolis, MN, USA) is the only commercially available leadless pacemaker. Since its first-in-human implantation in 2013, thousands of these devices have been implanted worldwide. This article presents an overview of the present clinical evidence and future perspectives of this promising new technology.
Check out the article’s website on Pubmed for more information:
This article is a good source of information and a good way to become familiar with topics such as:
Complications;Delivery system;Implantation;Infection;Single chamber pacing
Categories: Science News